resveratrol has been researched along with Grippe in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di Pietro, M; Filardo, S; Mastromarino, P; Sessa, R | 1 |
| Du, GH; Fang, JS; Li, C; Lian, WW; Liu, AL; Pang, XC | 1 |
1 review(s) available for resveratrol and Grippe
| Article | Year |
|---|---|
Therapeutic potential of resveratrol against emerging respiratory viral infections.
Topics: Antiviral Agents; Betacoronavirus; Communicable Diseases, Emerging; Coronavirus Infections; COVID-19; Humans; Influenza, Human; Pandemics; Pneumonia, Viral; Respiratory Syncytial Virus Infections; Respiratory Tract Infections; Resveratrol; SARS-CoV-2; Virus Diseases | 2020 |
1 other study(ies) available for resveratrol and Grippe
| Article | Year |
|---|---|
In vitro antiviral effects and 3D QSAR study of resveratrol derivatives as potent inhibitors of influenza H1N1 neuraminidase.
Topics: Animals; Antiviral Agents; Cell Line; Dogs; Drug Design; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Molecular Docking Simulation; Neuraminidase; Orthomyxoviridae Infections; Quantitative Structure-Activity Relationship; Resveratrol; Stilbenes | 2015 |